This article provides a detailed roadmap for designing robust ELSI (Ethical, Legal, and Social Implications) studies integrated within Recall-by-Genotype (RbG) research frameworks.
This article examines the critical tension between the Western principle of individual self-determination and the East Asian principle of family-determination within Asian bioethics.
This article provides a comprehensive analysis of Buddhist perspectives on medical ethics and end-of-life care, tailored for researchers, scientists, and drug development professionals.
This article examines the critical limitations of applying Western, individualistic models of autonomy in Asian biomedical contexts.
This article provides clinical researchers and drug development professionals with a data-driven framework to analyze, manage, and reduce clinical trial protocol amendments.
This article provides drug development researchers and regulatory professionals with a strategic guide to navigating the distinct regulatory landscapes of the FDA and EMA for submission amendments.
This article provides a comprehensive guide for researchers and drug development professionals on navigating the Institutional Review Board (IRB) amendment review process.
This article examines the critical relationship between clinical trial protocol complexity and the frequency of subsequent amendments, a major driver of cost and delay in drug development.
This article provides a comprehensive analysis of protocol amendments in commercial and academic clinical trials, offering critical insights for researchers, scientists, and drug development professionals.
This article provides a comprehensive comparison of amendment processes across clinical research, regulatory, and constitutional systems.